|
Vaccine Detail
rHVT-H5 |
Vaccine Information |
- Vaccine Name: rHVT-H5
- Target Pathogen: Influenza virus
- Target Disease: Influenza (flu)
- Vaccine Ontology ID: VO_0004633
- Type: Recombinant vector vaccine
- Status: Research
- Host Species for Licensed Use: Chicken
- Vector:
- Preparation: A recombinant turkey herpesvirus (rHVT)-AI vaccine, rHVT-H5, was used to express the HA gene of a highly pathogenic avian influenza (HPAI) H5N1 clade 2.2 A/Swan/Hungary/499/ 2006 strain inserted into FC-126 strain of HVT vector (Soejoedono et al., 2012).
- Immunization Route: Intramuscular injection (i.m.)
|
Host Response |
Chicken Response
- Vaccine Immune Response Type: VO_0003057
- Efficacy: Challenge was performed at 28 days of age using a different H5N1 isolate, clade 2.1.3 A/Ck/Purwakarta-Cilingga/142/10. Clinical protection was 95%, 75%, and 90% in Group 1, 2, and 3, respectively. Shedding of challenge virus was significantly lower in the vaccinated groups compared with controls in both experiments (Soejoedono et al., 2012).
|
References |
Soejoedono et al., 2012: Soejoedono RD, Murtini S, Palya V, Felföldi B, Mató T, Gardin Y. Efficacy of a recombinant HVT-H5 vaccine against challenge with two genetically divergent Indonesian HPAI H5N1 strains. Avian diseases. 2012; 56(4 Suppl); 923-927. [PubMed: 23402113].
|
|